Request for Covid-19 Impact Assessment of this Report
The United States MSD Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global MSD Drugs market, reaching US$ million by the year 2028. As for the Europe MSD Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main MSD Drugs players cover AbbVie, Amgen, Johnson & Johnson, and Roche, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of MSD Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
OTC
Rx Drugs
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Retail Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AbbVie
Amgen
Johnson & Johnson
Roche
Pfizer Inc
Eli Lilly
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global MSD Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for MSD Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for MSD Drugs by Country/Region, 2017, 2022 & 2028
2.2 MSD Drugs Segment by Type
2.2.1 OTC
2.2.2 Rx Drugs
2.3 MSD Drugs Sales by Type
2.3.1 Global MSD Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global MSD Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global MSD Drugs Sale Price by Type (2017-2022)
2.4 MSD Drugs Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.5 MSD Drugs Sales by Application
2.5.1 Global MSD Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global MSD Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global MSD Drugs Sale Price by Application (2017-2022)
3 Global MSD Drugs by Company
3.1 Global MSD Drugs Breakdown Data by Company
3.1.1 Global MSD Drugs Annual Sales by Company (2020-2022)
3.1.2 Global MSD Drugs Sales Market Share by Company (2020-2022)
3.2 Global MSD Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global MSD Drugs Revenue by Company (2020-2022)
3.2.2 Global MSD Drugs Revenue Market Share by Company (2020-2022)
3.3 Global MSD Drugs Sale Price by Company
3.4 Key Manufacturers MSD Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers MSD Drugs Product Location Distribution
3.4.2 Players MSD Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for MSD Drugs by Geographic Region
4.1 World Historic MSD Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global MSD Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global MSD Drugs Annual Revenue by Geographic Region
4.2 World Historic MSD Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global MSD Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global MSD Drugs Annual Revenue by Country/Region
4.3 Americas MSD Drugs Sales Growth
4.4 APAC MSD Drugs Sales Growth
4.5 Europe MSD Drugs Sales Growth
4.6 Middle East & Africa MSD Drugs Sales Growth
5 Americas
5.1 Americas MSD Drugs Sales by Country
5.1.1 Americas MSD Drugs Sales by Country (2017-2022)
5.1.2 Americas MSD Drugs Revenue by Country (2017-2022)
5.2 Americas MSD Drugs Sales by Type
5.3 Americas MSD Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC MSD Drugs Sales by Region
6.1.1 APAC MSD Drugs Sales by Region (2017-2022)
6.1.2 APAC MSD Drugs Revenue by Region (2017-2022)
6.2 APAC MSD Drugs Sales by Type
6.3 APAC MSD Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe MSD Drugs by Country
7.1.1 Europe MSD Drugs Sales by Country (2017-2022)
7.1.2 Europe MSD Drugs Revenue by Country (2017-2022)
7.2 Europe MSD Drugs Sales by Type
7.3 Europe MSD Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa MSD Drugs by Country
8.1.1 Middle East & Africa MSD Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa MSD Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa MSD Drugs Sales by Type
8.3 Middle East & Africa MSD Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of MSD Drugs
10.3 Manufacturing Process Analysis of MSD Drugs
10.4 Industry Chain Structure of MSD Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 MSD Drugs Distributors
11.3 MSD Drugs Customer
12 World Forecast Review for MSD Drugs by Geographic Region
12.1 Global MSD Drugs Market Size Forecast by Region
12.1.1 Global MSD Drugs Forecast by Region (2023-2028)
12.1.2 Global MSD Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global MSD Drugs Forecast by Type
12.7 Global MSD Drugs Forecast by Application
13 Key Players Analysis
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie MSD Drugs Product Offered
13.1.3 AbbVie MSD Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen MSD Drugs Product Offered
13.2.3 Amgen MSD Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson MSD Drugs Product Offered
13.3.3 Johnson & Johnson MSD Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche MSD Drugs Product Offered
13.4.3 Roche MSD Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Pfizer Inc
13.5.1 Pfizer Inc Company Information
13.5.2 Pfizer Inc MSD Drugs Product Offered
13.5.3 Pfizer Inc MSD Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pfizer Inc Main Business Overview
13.5.5 Pfizer Inc Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly MSD Drugs Product Offered
13.6.3 Eli Lilly MSD Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
14 Research Findings and Conclusion
Table 1. MSD Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. MSD Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of OTC
Table 4. Major Players of Rx Drugs
Table 5. Global MSD Drugs Sales by Type (2017-2022) & (K Units)
Table 6. Global MSD Drugs Sales Market Share by Type (2017-2022)
Table 7. Global MSD Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global MSD Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global MSD Drugs Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global MSD Drugs Sales by Application (2017-2022) & (K Units)
Table 11. Global MSD Drugs Sales Market Share by Application (2017-2022)
Table 12. Global MSD Drugs Revenue by Application (2017-2022)
Table 13. Global MSD Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global MSD Drugs Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global MSD Drugs Sales by Company (2020-2022) & (K Units)
Table 16. Global MSD Drugs Sales Market Share by Company (2020-2022)
Table 17. Global MSD Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global MSD Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global MSD Drugs Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers MSD Drugs Producing Area Distribution and Sales Area
Table 21. Players MSD Drugs Products Offered
Table 22. MSD Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global MSD Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global MSD Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global MSD Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global MSD Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global MSD Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global MSD Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global MSD Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global MSD Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas MSD Drugs Sales by Country (2017-2022) & (K Units)
Table 34. Americas MSD Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas MSD Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas MSD Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas MSD Drugs Sales by Type (2017-2022) & (K Units)
Table 38. Americas MSD Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas MSD Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Americas MSD Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC MSD Drugs Sales by Region (2017-2022) & (K Units)
Table 42. APAC MSD Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC MSD Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC MSD Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC MSD Drugs Sales by Type (2017-2022) & (K Units)
Table 46. APAC MSD Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC MSD Drugs Sales by Application (2017-2022) & (K Units)
Table 48. APAC MSD Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe MSD Drugs Sales by Country (2017-2022) & (K Units)
Table 50. Europe MSD Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe MSD Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe MSD Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe MSD Drugs Sales by Type (2017-2022) & (K Units)
Table 54. Europe MSD Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe MSD Drugs Sales by Application (2017-2022) & (K Units)
Table 56. Europe MSD Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa MSD Drugs Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa MSD Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa MSD Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa MSD Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa MSD Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa MSD Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa MSD Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa MSD Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of MSD Drugs
Table 66. Key Market Challenges & Risks of MSD Drugs
Table 67. Key Industry Trends of MSD Drugs
Table 68. MSD Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. MSD Drugs Distributors List
Table 71. MSD Drugs Customer List
Table 72. Global MSD Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global MSD Drugs Sales Market Forecast by Region
Table 74. Global MSD Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global MSD Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas MSD Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas MSD Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC MSD Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC MSD Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe MSD Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe MSD Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa MSD Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa MSD Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global MSD Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global MSD Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global MSD Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global MSD Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global MSD Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global MSD Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global MSD Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global MSD Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. AbbVie Basic Information, MSD Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. AbbVie MSD Drugs Product Offered
Table 94. AbbVie MSD Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. AbbVie Main Business
Table 96. AbbVie Latest Developments
Table 97. Amgen Basic Information, MSD Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Amgen MSD Drugs Product Offered
Table 99. Amgen MSD Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Amgen Main Business
Table 101. Amgen Latest Developments
Table 102. Johnson & Johnson Basic Information, MSD Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Johnson & Johnson MSD Drugs Product Offered
Table 104. Johnson & Johnson MSD Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Johnson & Johnson Main Business
Table 106. Johnson & Johnson Latest Developments
Table 107. Roche Basic Information, MSD Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Roche MSD Drugs Product Offered
Table 109. Roche MSD Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Roche Main Business
Table 111. Roche Latest Developments
Table 112. Pfizer Inc Basic Information, MSD Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Inc MSD Drugs Product Offered
Table 114. Pfizer Inc MSD Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Pfizer Inc Main Business
Table 116. Pfizer Inc Latest Developments
Table 117. Eli Lilly Basic Information, MSD Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Eli Lilly MSD Drugs Product Offered
Table 119. Eli Lilly MSD Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Eli Lilly Main Business
Table 121. Eli Lilly Latest Developments
List of Figures
Figure 1. Picture of MSD Drugs
Figure 2. MSD Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global MSD Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global MSD Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. MSD Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of OTC
Figure 10. Product Picture of Rx Drugs
Figure 11. Global MSD Drugs Sales Market Share by Type in 2021
Figure 12. Global MSD Drugs Revenue Market Share by Type (2017-2022)
Figure 13. MSD Drugs Consumed in Hospital
Figure 14. Global MSD Drugs Market: Hospital (2017-2022) & (K Units)
Figure 15. MSD Drugs Consumed in Retail Pharmacy
Figure 16. Global MSD Drugs Market: Retail Pharmacy (2017-2022) & (K Units)
Figure 17. Global MSD Drugs Sales Market Share by Application (2017-2022)
Figure 18. Global MSD Drugs Revenue Market Share by Application in 2021
Figure 19. MSD Drugs Revenue Market by Company in 2021 ($ Million)
Figure 20. Global MSD Drugs Revenue Market Share by Company in 2021
Figure 21. Global MSD Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global MSD Drugs Revenue Market Share by Geographic Region in 2021
Figure 23. Global MSD Drugs Sales Market Share by Region (2017-2022)
Figure 24. Global MSD Drugs Revenue Market Share by Country/Region in 2021
Figure 25. Americas MSD Drugs Sales 2017-2022 (K Units)
Figure 26. Americas MSD Drugs Revenue 2017-2022 ($ Millions)
Figure 27. APAC MSD Drugs Sales 2017-2022 (K Units)
Figure 28. APAC MSD Drugs Revenue 2017-2022 ($ Millions)
Figure 29. Europe MSD Drugs Sales 2017-2022 (K Units)
Figure 30. Europe MSD Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa MSD Drugs Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa MSD Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Americas MSD Drugs Sales Market Share by Country in 2021
Figure 34. Americas MSD Drugs Revenue Market Share by Country in 2021
Figure 35. United States MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC MSD Drugs Sales Market Share by Region in 2021
Figure 40. APAC MSD Drugs Revenue Market Share by Regions in 2021
Figure 41. China MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. India MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe MSD Drugs Sales Market Share by Country in 2021
Figure 48. Europe MSD Drugs Revenue Market Share by Country in 2021
Figure 49. Germany MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. France MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa MSD Drugs Sales Market Share by Country in 2021
Figure 55. Middle East & Africa MSD Drugs Revenue Market Share by Country in 2021
Figure 56. Egypt MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country MSD Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of MSD Drugs in 2021
Figure 62. Manufacturing Process Analysis of MSD Drugs
Figure 63. Industry Chain Structure of MSD Drugs
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...